Q3 2019 Earnings Call

Ladies and gentlemen, good day and welcome to the Advansix third quarter 29, <unk> earnings Conference call Today's conference is being recorded.

After today's presentation, there will be an opportunity to ask questions to ask a question you May Press Star then one on your telephone keypad withdraw your question. Please press Star then too.

Now, let's turn the conference over to Mr., Adam Crystal Director of Investor Relations. Please go ahead Sir.

Thank you David Good morning, and welcome to advance, Texas third quarter 2019 earnings Conference call.

With me here today, our president and CEO earn Kane and senior Vice President and CFO Michael Preston.

This call and web cast, including any non-GAAP reconciliations are available on our website at investors Dot Advansix Dot com.

Note that elements of this presentation contains forward looking statements that are based on our best field, the world and of our business as we see it today.

Those elements can change and the actual results could differ materially from those projected and we ask that you consider them in that light.

We refer you to the forward looking statements included in our press release and earnings presentation. In addition, we identified the principal risks and uncertainties that affect our performance in our SEC filings, including our annual report on Form 10-K .

This morning will review our financial results for the third quarter 29 gene and share with you our outlook for our key product lines in end markets. Finally, we'll leave time for your questions at the end so with that I'll turn the call over to advance six as president and CEO Aaron King.

Thanks, Adam and good morning, everyone. Thank you for joining us and for your continued interest in advance X.

As you saw in our press release Advansix navigated a third quarter characterized by a challenging end market environment. As you saw further slowdown in demand what they said.

Nine one industry conditions in particular remain lack luster with a sequential decline in in this industry spread that began in June persisting for the third quarter.

Michael do you tell the whole results in a moment, but overall.

Third quarter results were pressured by challenging industry conditions and on favorable product mix, given our global low cost position, we continue to benefit from strong plant utilization rate at help on particular interfaces slowing island demand continued acetone oversupply conditions and next fertilizer industry dynamics.

We have remain committed to the deployment of Capex. This year in high return growth in cost savings projects, our new natural gas boilers are fully on stream, which coupled with low natural gas prices are delivering immediate productivity benefits for our business.

And lastly, we repurchased approximately $13 million of shares in the third quarter.

I'm also proud to announce at our Frankfurt facility was awarded RC 14001 started vacation in September with that certification all Advansix facilities are now third party certified.

<unk> RC 14001 end here to the responsible care guiding principles set forth by the American Chemistry Council. We continue to have the sharp focus on safety and advancing and sustainable enterprise.

We're in the midst of completing our planning for 2020 with a conservative outlook in the near term as macro uncertainty continues to weigh on market sentiment.

Importantly, we are taking proactive measures to drive disciplined cost management optimize working capital performance in cash flow generation, while deploying capital prudently.

We remain focused on continuing to execute our strategic priorities with operational efficiency.

And he is will support our long term performance.

We continue to track to approximately a hard and $50 million in capital expenditures in 2019, which as a reminder, funds three key investments this year, including our natural gas boilers, caprolactam de bottlenecking and R&D lab relocation projects.

He will bolster our underlying earnings potential.

Looking to 2020, we expect total capex in the range of $90 million to $110 million or down 40 to 60 million year over year.

Given the end market environment, we will be disciplined around reinvestment in the business, while working to mature or long term pipeline of high return opportunities.

I'm happy to report that our fourth quarter 29 team plant turnaround was recently completed as expected and we'll have an approximately 25 million dollar impact a pretax income in the fourth quarter.

Lowland of our previously expected range. This is a key considerations our earnings performance in the fourth quarter and will bring the total planned turnaround impact for the full year to approximately $35 million.

The full year 2020, we expect a pretax income impact of plant plant turnarounds to be in the range of 33 to 38 million, which will be heavily concentrated in the second quarter of next year [laughter].

Lastly, I want to provide an update on accumulate supply chain fine refinery fire at one of our suppliers, Philadelphia energy solutions or P.S. and Jim in the third quarter. We saw a roughly 4 million dollar pretax income impact as a result of our extended supply chain below the expected range, we provided last quarter.

Given the proximity of P.S. operations relative to our Frankfurt phenol plant, we inherently drive logistics and working capital benefits from that local supply relationship.

As we are shifting towards a more golf coast. Your line supply. Our teams are actively working to optimize the impact on our business, including logistics spot purchases and buffer inventory levels.

Given our efforts we've narrowed the expected range at the fourth quarter 2019 financial impact of 46, $9 and expect the full year 2020 impact to be in the range of 10 to 15 [noise].

Million compared to a full year 2019 impact of $8 million to $10 million.

Our key focus is to ensure a security of supply and optimize economics as we realigned our supply chain to 2020, I mean do remain confident in our long term Optionality [noise].

With that I'll turn it over to Mike to discuss the details at the quarter.

Yeah, Thanks, Aaron and good morning, everyone I'm now on slide four where I'll review the third quarter financial results.

Sales were 311 million in the quarter down 16% compared to last year [laughter] pricing overall was unfavorable by about 14%, a 14% and that was primarily due to an 11% unfavorable impact from raw material pass through pricing falling cost decreases in both benzene and propylene.

Market based pricing was unfavorable by approximately 3% compared to the prior year [laughter]. This reflects challenging end market conditions, and acetone nylon and capital like Pam, partially offset by improved ammonium sulfate performance.

Volume overall was down about 2%, primarily due to sales timing and unfavorable product mix across nylon and ammonium sulfate driven impart by operational performance and continued challenging industry dynamics in chemical intermediates.

Partially offsetting this was improved caprolactam volume due to stronger utilization rates and the larger planned plant turnaround in the prior year period.

[noise] EBITDA was 25 million in the quarter, Oh, that's up about 5 million versus the prior year.

The increase primarily reflects an approximately 25 million dollar net favorable year over year impact unplanned plant turnarounds. This was partially offset by the unfavorable impact of market based pricing lower volume operational performance and other factors as well as the unfavorable cuming impact as Aaron mentioned.

Earnings per share of sort of 28 cents increased by 56% versus the prior year driven by the factors just discussed and a lower share count driven by continued repurchases.

Lower share count can contribute into two cents of vps accretion year over year.

In 2019 through the end of October we've repurchased approximately $62 million worth of shares and since the inception of our authorization, we've now repurchased roughly 12% of our total shares outstanding.

And lastly, cash flow from operations reached 33 million in the quarter, that's down about 17 million compared to last year, primarily due to the unfavorable impact of changes in working capital.

Capex of 35 million was up roughly 16 million year over year due to higher planned turnaround maintenance spend as expected and continued execution against our pipeline of high return growth in cost savings capital projects.

Now, let's turn to slide five for a deeper dive into our earnings performance relative to last quarter.

As we had previewed on our last earnings call. There were a number of on of known Tailwinds and headwinds to our sequential performance in the third quarter relative to the second quarter 2019.

First is the pricing and mix impact of the typical seasonality in our ammonium sulfate business as we've highlighted in the past ammonium sulfate prices are typically strongest domestically during the second quarter fertilizer application and then have a seasonal pricing decline into the third quarter as a new season begins.

We also have a greater mix of products sold to our export markets in the third quarter. This results in the higher standard grade product sales in the third quarter versus strong granular sales domestically at the height of the North America season in the second quarter.

On average we can see a roughly a $50 per ton premium for granular product compared to a standard product in total we saw the sequential seasonality consideration towards the midpoint of the $10 million to $15 million range, we typically see in our Cogs in the third quarter.

Second on the list of key sequential performance drivers is the approximately 12.6 million pretax repositioning charge associated with the closure of our Pottsville, Pennsylvania fills manufacturing facility that did not repeat in the third quarter.

We're continuing to qualified customers and build upon our strategic alliance with open group, which we expect will position us for continued success in the nylon films industry. [laughter]. In addition to these factors. We also saw incremental headwinds impacting our performance in the quarter from an industry perspective, Aaron will detail, what we're seeing in each of <unk>.

Eric lives in a moment, but in addition to is yes seasonality market pricing for all the products represented an approximately 6 million dollar headwind sequentially.

The challenging dynamics and acetone have persisted, which has kept pressure on pricing in spreads demand has remained soft across most nylon end uses as well with industry benzene a careful liked him spreads near their recent 2016 lows.

As we previewed there wasn't approximately 4 million unfavorable impact a pretax income in the quarter as a result of the P.S. supplier fire and extended Q mean supply chain. The impact this quarter came in below the range. We provided on our last earnings call and we continue to optimize accumulate supply chain as we go forward.

Lastly, we saw in approximately 1 million that headwind sequentially from volume operational performance and other factors. Despite some unfavorable impact related to fixed cost absorption and lower yields our capital liked him and all the unit operation utilization rates out Hopewell remained relatively high as we benefit from a global low cost position.

Importantly, we also began to see benefits from our new natural gas boilers in the third quarter. The returns for that project. Thus far has exceeded our expectations now let me turn the call back to Aaron.

Thanks, Mike I'm now on slide six to discuss our nylon product line, which includes our caprolactam resin and films products and represented just over 50% of ourselves in the third quarter.

As you can see from the chart on the right hand side of the page industry benzene to caprolactam spread globally as well as Asia caprolactam to resin spreads continue to declined sharply on a year over year basis in the third quarter as you'll recall, we began to see a sequential step down in industry spreads it really take hold and Jim which are then sustain through the third quarter.

Asia, Bendini caprolactam industry spread average roughly $775 per ton in a third quarter and dipped below $700 per ton in September approaching the trough. Most recently seen in 2016.

We did see an increase in the Asia caprolactam to resin spread on a sequential basis in the third quarter from the second the spread does continue to hover in and around that marginal conversion cost of monomer to Palmer of approximately $250 per ton.

As we look at an idle on environment overall, we've seen slowing growth in uncertain market sentiment continue to weigh on pricing and spreads.

And use application perspective, we've seen persistent weakness in north American carpet as well as an auto end markets, particularly in Europe , and China, and a slowdown in textile demand growth out of Asia.

We've also been operating in a falling commodity input environment, but a global commodities such as benzene among in software for example, falling in recent months and in most cases these costs dropping more rapidly in other regions as compared to the U.S.. We've seen the global caprolactam cost curve flattening on these weaker feedstocks, which has pressured industry spreads and pricing [noise].

But her bus operating performance in the U.S. and a net export position, we do anticipate greater exports moving forward in the current demand environment. So while they continue to actively work on upgrading our product mix into higher value applications, such as engineering plastics and adapt to changes in light of the softer end marketing conditions, our geographic sales next we'll shift accordingly.

Despite industry growth year over year, continuing to decelerate, our global low cost advantage will serve us well as we focus on realigning our end market sales next let's turn to slide seven.

In ammonium sulfate, which represented about 20% of our total sales in the quarter bizarre typical seasonality impact moving from the second quarter to the third as Mike discussed.

Based on third party data, we've seen relative stability in corn belt ammonium sulfate industry pricing as compared to nitrogen pricing overall as a reminder, urea is the largest nitrogen fertilizer by total consumption and tends to have an underlying influence on all other nitrogen nutrient products.

Fertilizer industry pricing in the third quarter declines on both year over year basis, as long as seasonally versus the second quarter [laughter] nitrogen fertilizer pricing overall has continued to be dynamic fine the adverse weather in industry logistics disruptions seen earlier in the year [noise].

Agricultural fundamentals have remained challenging overall in the recent U.S.T. a crop estimates published last month reaffirmed corn yield projections, which in turn have supported range bound movement in those corn prices [laughter] as he loved towards the remainder of the year and into 2020, we expect to see fertilizer demand strengthen seasonally, particularly as we move into the heart of the domestic planting season next year.

We do expect to see some increased competitive pressure in light of announced ammonium sulfate capacity additions and continued European imports will also continue to watch for any changes in expectations for planted acres. Instead next domestic planting season, while remaining focused on delivering the value proposition of sovereign attrition for our customers globally.

Let's turn to slide eight for an update on chemical intermediates.

I Kinda intermediates product line represented just under 30% of our total sales in the quarter. The chart on the right hand side of the page again shows refinery grade propylene costs and U.S. acetone prices based on third party data the industry realized after trim price every raws continued to be compressed in challenged overall through the third quarter despite importance.

The U.S. moderating global acetone remained an oversupplied position on the back of weaker demand as a result, we've seen pressure on spot market spreads and they continue drive for deeper discounts in the large fire market.

From an acetone demand perspective, nothing soccer later, and then may industry conditions have remained weak overall on a global basis as a reminder, M&A as a key consumer of acetone, particularly here in the U.S. and is using various acrylics plastics in coatings, which ultimately end up in applications tied to auto or housing markets.

So a couple with an overall slow down on global basis. We've also seen delayed restarts said M&A customer plants. Following downtime earlier in the year as well as further plants plant turnarounds at a cap demand you did.

Being on demand has also remained subdued globally, we've seen softness across key end uses such as this one I'll answer polycarbonate and proxy resin and of course nylon as we've discussed.

Across the remainder of our chemical intermediates portfolio, we have seen demand remain rather resilient, albeit off a smaller base with continued favorable growth trends associated with our oximeter and other derivatives.

Lastly, I will need to take the opportunity provide an update on the ongoing acetone anti dumping petition as a reminder of the U.S. Department of Commerce has issued preliminary anti dumping duties on five countries over the past few months.

Starting with the first two countries, Singapore in Spain, but did not contested petitions the D O C and now its final determinations in mid October confirming their initial Judy rates. The International Trade Commission is expected to issue final injury determination on those two countries by mid November .

That's where the other three countries, Belgium, South Africa in South Korea, where awaiting final dumping determinations Vida DLC and finally injured injury determination by the ITC, which is expected by the first quarter 2020 [noise].

Sending affirmative rulings duties imposed will be in place for five years I, Let me turn the call back over to Mike. Okay. Thanks, Aaron I'm now on slide nine to discuss our Capex framework.

Following 109 million of cash outflow from Capex in 2018, we're tracking to approximately 150 million in full full year 2019, followed by a reduction in 2022 unexpected range of 90 to 110 million or down 40 to 60 million year over year.

As we've shared in the past spend in 2018 in 2019 includes the two high return projects. We have initiated the increase in 2019 and subsequent declined to 2020 is the result of several factors.

First relates to the previously announced $15 million of incremental capex associated with the relocation of our R&D facility from its current location lease from Honeywell into our own Chesterfield, Virginia site.

The second consideration relates to approximately 20 million in spend for planned plant turnarounds. This increase is being driven by the scope of the 2019 turned around as well as a timing of the 2020 turnaround scheduled for the spring requiring capex spend in 2019.

And lastly, we continue to be excited about the healthy pipeline organic investment opportunities that we expect it to drive ongoing benefits for years to comp.

However, given the current macro landscape, we will remain prudent around any discretionary deployment of capital as we further mature our high return project pipeline.

Now, let's turn to slide 10 is to discuss our outlook for the rest of this year end 2020.

As you can see on the right hand side of the page we've highlighted our expected trend for each of the key drivers of our performance with the Red circle, representing a headwind for next year yellow circle neutral and green representing a tailwind as we discuss there are some puts and takes across the portfolio from a commercial perspective in the nine months.

Phase, we we're characterizing environment is weaker overall, given the macro uncertainty and expect the current softness in end market demand to continue.

We continue to look to mitigate impacts from movements in key feedstocks and remain focused on value pricing or more differentiated now on products based on their performance characteristics in the higher value applications [noise].

In ammonium sulfate, we expect fertilizer prices and mix to increase seasonally as we're exiting the year and continue in into the heart of the North America planting season.

Overall indications point to a more dynamic ammonium sulfate fertilizer environment through the rest of the 2019 2020 planting season as a reminder, touring announced capacity additions estimated planted acres crop prices as well as global trade flows.

We also expect to see some level of pre buy cash advances in the fourth quarter for sales plans in 2020 as is common in that business as for chemical intermediates. We expect continued acetone price overall spread pressure for the remainder of the air on the back of slowing demand and persistent oversupply conditions, we do actually.

North America has its own inventory levels to stabilize over time and are awaiting final anti dumping duty determinations, which we expect to be announced if any by the first quarter 2020 [noise].

Operationally, we've completed our planned turnarounds for 2019 as of the fourth quarter and remain focused on the flawless execution of our turnaround schedule into the 2020, which as Aaron highlighted will be heavily weighted towards the second quarter of next year.

We expect continued improvement in performance across our integrated asset base in 2020 supported by a proactive maintenance and reliability programs.

I highlighted our expectations for Capex spend on the previous slide we continue to expect full year benefits from our new natural gas boilers at Hopewell in 2020.

As for the previously discussed caprolactam quite <unk> quality and Debottlenecking project, there's still remains very strategic project for us. Despite the current industry conditions were managing this project to cost and now expects to be fully online by the second quarter of next year [laughter]. We've also indicated our expected pre tax income impact in the fourth call.

For 2019, and full year 2020, as a result of or realigned Q means supply chain. Following the approximately 4 million unfavorable pre tax income impact in the third quarter of 2019, we expect a four to 6 million dollar impact in the fourth quarter.

In 2020, we expect an unfavorable impact in the range of 10 to 15 million, which represents a low to mid single digit million increase year over year.

Over the medium to long term, we see cuming supply and demand dynamics supportive a sufficient availability and continue to assess our long term optionality.

Lastly, we expect our effective tax rate to be in the range of 24% to 25% for the full year 2019, and approximately 25% in 2020 from a cash perspective, we expect continued to fishing working capital performance next year and pension cash contributions are expected to be in the range of $5 million to $10 million now let me turn the.

Fall back to earn for a brief wrap up before moving to Q and I.

Thanks, Mike.

I'll take the time to reiterate our core focus areas on slide 11, somewhat similar to what we shared last quarter, our key levers to drive that's possible outcomes and long term value creation haven't changed.

First they save on sustainable operations.

This is core to who we are as a company since it started 2017, our utilization rate at hope all has averaged roughly 93%, which has significantly outpaced the industry and it's critical for us to leverage our low cost caprolactam position globally. So while we've seen a significant improvement in how we operate our facilities the remains more to accomplish less variability in production quality and.

Ill drives higher returns for the business.

Second differentiated product growth they talked about this area focus in three different buckets high purity applications high value intermediates and differentiated nylon individually in many of these products are growing off of a small base and are still in early stages of development. We've had successes across the portfolio. For example, our nylon wire and cable sales have increased more than 50% year to date.

Well I easy blocks anti skinning agent used in paints has more than doubled its sales over the same period.

We're also building momentum and getting commercial traction on additional offerings.

So although the environment for the broader industries. We serve has been lackluster in the near term, we're well positioned to capitalize on any macro improvement and continue to expect to improve contribution from our focus on these two key areas [noise].

Finally cash generation into plan since the Stanley generated over $450 million, an operating cash flow, which has been deployed towards capital reinvestment debt pay down and share repurchases. We also continued to build out our inorganic pipeline and capability is consistent with the capital allocation priorities. We have previously discussed as always we'll remain disciplined in our approach.

As we look to drive long term shareholder value.

So we recognize that the current environment is challenging but we are very focused to continue to position. The company for a long term performance by executing on these strategic priorities, but that Adam let's move to QNX.

Thanks, Aaron and David You can go ahead and open the line for questions.

Thank you Sir we will now begin the question and answer session to ask your question you'd be a press star then one on your telephone keypad. If you are using a speakerphone. Please pick up your handset before pressing the keys to withdraw your question. Please press Star then to.

At this time, we will pause momentarily to assemble our roster.

Our first question will be Christian Moore with CJS Securities.

Hey, good morning, guys.

Good morning, maybe just with the though the P.S. far <unk>. The 10 to 15 million impact on 2020 can you can you break that down a little bit further and you know.

Trying to understand front from my comments this is that likely be permanent impacting the cost structure or still to be determined.

Yeah.

Yeah, Chris I'll take that yes, as you I will discuss in the past.

The the benefit of having P.S. as accumulate supplier was that they were very close or frankfurt's facility.

And we inherently had logistical and also working capital benefits.

As a result.

So now as we source accumulate from other sources that extends our supply chain.

With that you know quite a bit of logistics costs associated with that.

So when you look out the the 10 to 15 million dollar impact next year, a good chunk of that good large percentage that it's actually a logistics you know for chartering vessels are having them go down to the Gulf pick up additional material.

And come up you don't terms of Ah you know whether or not that's a a you know a permanent impact going forward. You know certainly no warrants P. S is down and we don't have local supply there is gonna be that consideration going forward. What I'll say is you know we continue to optimize cost where we get immune from Uh huh.

We manage our logistics or how we met or you know manage buffer supplies of cuming.

To mitigate that to the best and we can in fact, you saw that the actual results in the third quarter were below what we had guided and we continue to Ah you know to improve on on the impact of but we are going to be paid with an extended supply chain and the impact of that in terms of logistics that'd be helpful.

Gotcha.

With respect to you guys talked at the end kind of the higher value.

I'm products. It seems like you know that's.

<unk>, becoming more and more critical given that <unk> the current environment.

Roughly from my 2020 perspective, you know what what percentage of revenue do you see there and.

You know, what's the what's the ceiling.

So Chris My I can mean, a few things here.

As we look across the entire portfolio.

Dan we want to reiterate that.

The opportunity to grow differentiated products existing pretty bucket.

Hi, purity allocations, which is oh.

Any kind of geared inside of our intermediates portfolio now year to date, we've seen growth of 4% on in those product lines I'm in high value. The intermediate says well I've already noted the easy blocks and just getting agent on who had doubled their sales year to eight right. Those those to have an opportunity for us continue to work.

Into 2020 and beyond for those and then of course as you imagine differentiating nylon Oh, you know in general we recognize we have to continue to upgrade our mix as you point out.

We are doing very well on the the wire and cable with those sales doubled.

And as well as.

When you.

Okay. The number of 'em opportunities again, it's it's difficult we recognize we put this on a percent of sound said, but as the raw materials environment change, we're seeing more topline movement, it's still thing underlying performance being driven out of our pipeline.

So we're going to continue to be focused across.

Okay.

Oh product it's really.

You too however.

These product lines that have one unhappy to exit gross margin is our company average sad that will be a continued focus into 2020, <unk> and beyond and [noise].

We get into 2020, we recognize that.

Apparently here for you.

You know another data point I can provide and.

Next we have grown volumes into the engineering plastics, you know hunting faced by 5% well.

Not me realign our.

In our portfolio wherever you go and so we do anticipate that it will be a contributor so incremental earnings next year.

Okay.

Last question for me and I think you had mentioned that ammonium sulfate there.

New capacity coming online.

Where is that in and you know.

What are you know what do you expect from that.

Sure I mentioned in the past Chris.

Watching and I'm actually new transmission capacity is online in Western Canada on they converted and then on phosphate line too and on purpose ammonium sulfate line on adding roughly 350000 metric tons, which has doubled their current capacity I'm talking about 700000 times. So that's about 10 percentages.

No granular, yes into North America, you put that in perspective, we have imports into that.

Into the region of about 512000 metric tons, or I guess, I'm, which is up year over year.

So I think when we talk about.

Hi potential supply demand dynamic playing into this next season, I mean is that new capacity coming in as well as Powell that realized through that north American on balance so.

That's a chemo.

God I appreciate it I'll jump back in line. Thanks, guys.

Thank you. Thank you weren't next question comes from Charles Neivert with Cowen.

Hi, Good morning, Stuffers only on for Charles I'm, just wanted to see if you could touch on the supply side in a cop Rowan nylon <unk> have you seen anything recently come online in China, and and maybe your thoughts on heading into 2020, if you see any new.

Passive either.

Sure I mean, there continues to be I would say the.

I'll focus on continuing expansion if we look at sort of total capacity you know from 17 18 to 19, you know we've seen about another 500000 tons or so you know come on 18 to 19, which was on top of about 800000 tons of capacity.

No added and 18.

One other things that we are noticing is that while there are several announced capacity additions over the next several years I'm increasingly I would say that the from timing of those ads is becoming uncertainty and so there there is a.

At least a a view now that you know given the the fluctuations in supply demand.

You know when you look at China, you you have automotive in in decline I'm on the textile side has gone from double digit growth in 18 to low single digit growth on <unk> and 29 team, which is a large consumer a as nylon in the region.

So again I think we're watching but we would anticipate that those additional announcements on a couple hundred thousand tons give or take you know will continue to be on certain him likely push out.

Okay. Thanks, and maybe just could you maybe you acquired quantify what kind of benefits you're seeing from the new natural gas boilers in the copper road de bottlenecking versus in Three Q2 versus what you might.

Expecting 2020.

Yeah, Yeah, so when the.

When we talked about you know the high growth and the cost savings projects growth and cost savings projects. You know we have the to the boilers as you mentioned in the.

And the capital Debottlenecking projects.

When you add those two up you know as we've talked about in the past that's roughly 55 to 60 million of Capex and an internal rate of return of of 20%. A is what we anticipate you know in aggregate there.

As we talked about the boiler started up in the third quarter and we started to see benefits. What I'll say is where you know we're looking at low to mid single digit million kind of benefits from that and the you know the benefits or are exceeding our expectations. Overall you know the the boilers are operating as we anticipated and we are.

You are getting the returns the.

So and we expect to get sort of full year returns next year. So we'll get about a half the if you look year over year in 2020.

Yeah, we'll get another half a year or benefit compared to 2019.

When you look at the capital like 10, Debottlenecking project, you know that one as you can imagine and by the way the what we've talked about in the past was that would unleash about 2% of additional production additional capacity of caprolactam. A you know in the context of more challenging end market conditions, a we've been managing the pay.

Most of that one now to be more of a sort of a core cost driven project.

And therefore, we don't anticipate.

To start achieving benefits that project until you know the second quarter of of next year. So we'll have a bit of a ramp in the second quarter and then start to get you know sort of full run rate benefits in the second half.

Okay. Thanks very much.

Right. Thank you. Our next question comes from David Silver with see Okay.

I apologize your timing is exclusive the there's just a is fire alarm here.

I was wondering I was going to ask your question about maybe your thoughts about capital allocation or balance sheet.

Here, Yeah. During 2019, I mean, we've seen the a.

That level on your.

I guess [laughter] strategically you know I'm I'm sure, there's kind of a potential acquisition funnel or some ideas you have that may be.

Would utilize or strengthen your vertical integration may be diversified you went to diversify your your end markets.

Could integration or thought about strategic.

You know capital deployment going forward and.

This is versus.

<unk> balance sheet and in other words are you maintaining enough dry powder or financial flexibility to two you know take advantage of an opportunity you know.

[noise], Yeah, I got you David <unk> I'll try to yeah, I'll try to I'll try to answer that you were breaking up a little bit on our end here, but oh, well I'll try to answer that yeah first and foremost what I'll say is the you know the first priority David as we talked about is the reinvestment in the business.

Ah, particularly you know the capital expenditures.

Thank team, we anticipate spent about 150 million of of Capex and as we've talked about you know as well is really the step up in spend on these inorganic high return growth and cost savings projects of which were starting to get the benefits.

From those now and and you know again, we have a whole pipeline behind that of of growth in cost savings projects of 150 to 200 million with you know with you know with nice returns that we anticipate a 20% internal rate of returns that were going to continue to build a business cases on and do engineer.

Now going forward. So that is the that is the first a priority for us.

You know in terms of M&A or you know we are active in terms of Ah Ah looking out targets building a pipeline.

That you mentioned in terms of a you know improving our margins cash flow stability in the business vertical integration I mean, those are all things were interested in.

You know that we've been maturing in terms of building that by pipeline overtime.

And we you know that is a strategic priority for us, but the you know the first initial focus for US is the though the organic reinvestment.

Through Capex.

So and and so that is that as the another focus area.

Okay. Thanks, Thanks for that if I could switch over to this slide you have on acetone.

And.

You know I know that the line as you know charting the benchmark pricing or you know or just sat there kind of benchmark pricing, but [noise].

You know if I kinda volleyball would if I look at a 40% year over year decline in acetone pricing I mean that.

Kind of on the order of 25 cents, a pound or you know more than a thousand dollars a short.

Ton.

I'm, sorry, I'm getting my NAV picks up but 25 cents a town.

And.

Hi, you know first of all I'm, just wondering is that the type of year over year difference that you're seeing on your acetone realizations.

And then I'm just wondering if you could maybe remind us what your break down of sales might be between you know the small medium buyer market and the large buyer market. Thank you.

Turning to let me.

Take a stab at that for you. So when the first of all from the breakdown perspective, you know ourselves to be in line with really the market.

Share of large fire versus small medium by which would be you know two thirds weighted to the large fire you know a third weighted to you know the small medium.

You know give or take and it when you think about you know it certainly has a line charts luck vis-a-vis you know the propylene.

[laughter] doing you look at sort of where we've been cycle average as you know the long term average on that spread is probably closer to you know a nine cents is spread on online.

I mean, propylene and any appetite south and certainly we are [laughter] now spreads that have been I'm quite compressed for that long term average and part of that is.

When you have lengthened the market. The this small medium buyer market tends to be more or they really negotiated orientation. I mean also has historically been priced and at a premium or at least you earn margin because you're in.

LTL truckload, you know more customer service into those oriented types of.

Market that was the first space that has seemed quite a bit of compression as you can see from the line chart, you announced kind of almost collapse on top of one. Another so that is that is the area of the market that you know we looked to have improved you never return performance.

Given not that we should see premiums there and then certainly the large market will improve but that often used improve along with the health of the M&A market as well.

Okay, and I'm, assuming that and correct me, if I'm wrong, but as the anti dumping you know investigation and determination rulings you know flow through and take effect in the market I mean, I would I be correct in assuming that that.

To be.

<unk>, principally affecting the large buyer market.

We gave me wed anticipate that Tom on.

On a true affirming is determination.

We see a few things having to play out first the acetone inventory you know needs to work through the system on and we need to have healthy M&A on demand to do that and so you know we look to those key and consumers for their plant facilities and their end market to to improve and.

Then we have that you know certainly.

Given are they the reduction in the imports you know returned to more fair and disciplined I'm you know orientation of outside of those imports that inherently you would see you know could see you know there the return on on [noise].

Spreads rising in both the small medium buyer market as well as a large buyer.

Yeah, Yeah, there's one or want to lead I guess.

Okay, and just to reiterate you in your prepared remarks, you said that despite the initial determination.

Regarding antidumping.

Duties.

The tone of the market to this point because those are really show no improvement and is that you know, sometimes we say month to month, but you know would you say that September October is similar to a July and August or you know or would you say the average of three Q over twoq.

It was what.

Has not improved.

I always say you know there's been modest.

You know sentiment, but again I think he this supply demand lengths and you know has been right.

Really the broader umbrella story here then what can happen in a short term you know indication and again those affirmative duties you know if final will be in place for five years and that is again the long term view that we've been taking care with petition.

Okay. So oh, sorry, if it's going to play play out over a period of time alright. Thank you very much appreciate it.

Hi, Thank you do.

Thank you ladies and gentlemen, again, if you have a question. Please press Star then one our next question comes from Vincent Anderson with Stifel.

Yes. Thanks.

Nice job on the turnaround this quarter.

I wanted to start with those volumes sulfate and just to clarify have you seen actual signs already or of the impact from the new North American capacity from your distributors and retailers or is it too early.

It really is too early here Vincent right. They plan just now online and you can see no telling other you know company Q3 is really the start of the next season, it's been rather I would say quiet today, but some funny that we definitely need to watch as me as we get into the high that's either.

Okay. Thank you and then I was hoping you could go into a little bit more detail on what's the kind of the near term commercialization plan is for increasing your dialogue utilization rates. Since that's kind of demand environment is this is it all going to be through value add or you're playing to go back after market share.

So maybe I could help refrain you really are sentiment well when we talk about.

You know high utilization, our core focus as they as they've talked is really around.

Stacey.

Stable unsustainable operation and when we run more daily more reliably we are inherently getting more right out of our facility I mean that is really our focus.

Versus if you will say and I you know not to interpret that they comment that we're moving a dials right from that perspective, certainly the de bottlenecking project will give us inherently more capacity, but much of our performance really just coming from the the long term I would say.

Latent opportunity has existed inside our asset base. It as they continue to be proactive and driver mechanical integrity and maintenance excellence programs, we're getting the benefits and returns.

So.

Again targeting perspective, it is around continuing on our core strategies with the strong belief and quite candidly. They the demonstration over the last several quarters that the methodologies and the strategy works to get more out of that other plants now with that we need to make sure that we're working hard as you pointed out you know on.

The mix of those.

So in in the actual nylon conversation facility.

It's barely we're working to realign our mix you know as carbon has continued to come under pressure.

To to move our mix to allow us to reach into the compounding space.

To support independent contractors, and others with high quality good products to compound and meet engineering plastics need onto a focus on higher value high viscosity products for packaging as well as you know doing new things like Oh polymerization various types of termination that allows us to to get it.

This application based so that's really the focus there and hopefully that provides a little bit more context to the notion of.

You know they're talking to utilization.

That's helpful. Thank you and actually going back to the operations during the turnaround this quarter were there any specific changes to the exercise or investments made that that really helps that performance and give you added confidence in or turnaround costs kind of remaining lower more predictable going forward.

Sure you know one other things that we do and have continued over the last several years isn't this a need we've talked about there's probably several quarters ago is a focus I'm only color global turnaround strategies. So we've been focusing on I'm looking at how it's who we integrate our schedule as I'm looking.

At Wrench time alignments, you know how do we take waste out of the daily work right to increase the wrench time, we've seen great success last year in our Kellogg ammonia turnaround on we applied the same techniques and got the same benefit here.

Out of us or ferric acid plant turnaround so lot of integration lot more coordination using new techniques and you know that are I mean, perhaps lean in nature are right to get waste out of that the timeline and I get your wrench time up a lot of key focus on start up as well I think we've had learnings that we can do really well and execute on the wrench time, but we also.

We need to flawlessly execute on our startup.

It has been a keen focus and as we head into you know next year, we're adding a new layer in looking at how we can also mitigate our raw material purchases.

Yeah that had been a a key cost for us, particularly let me take down the sulfuric acid plant or they tell us ammonia plant, but obviously, if we can start to leverage our own you know materials and thinking about how to be creative.

And and mitigate that cost you know that will be new for 2020 as well.

Thanks, and just two more quick ones, if I can sneak them and I'm, just I'm going into 2020 or would it be possible for you to quantify the year over year savings. If we were to hold sulfur prices, where they are today, given how much they're falling through the year.

Oh, Yeah, we'll well off to get back to on that but the as you saw the you know sulfur has come down if you look at some of the recent industry pricing were sort of in the in the $50 per tonne a level.

That I would say is pretty low relative to what we had seen in the prior year. So that you know question is whether or not that as a stable price and we will be sustained as we go.

Into next year, but if that is the case you know that will certainly be a you know a bit of tailwind for us a next year.

Great. Thanks.

Last one just looking a little bit more long term you know you've talked about derivative products as a as a focus.

Today, a potential M&A I should say have your thoughts on those targets maybe shifted away from the Q me in value chain, given the feedstock uncertainty there.

The only thing you point out an interesting you I think our strategies as Mike alluded to before you know remain I.

You know the same in the interest to how do we continue to look at opportunities I'm thinking about the value.

Long our product lines, you know as as new opportunities, but certainly hopefully it's coming through.

Ensuring that we have the right long term optionality sorted for I.Q. mean strategy comes to some of the front of the list. If you will particularly if we're gonna go down that value chain. So I think it's the good observation and one that we're working on.

Oh, thanks, so much.

Like you occasionally we have no further questions. So alternative back to Miss Aaron came before closing remarks.

Great. Thank you all again for your time and interest this morning as they continue to navigate through challenge and market conditions. We are focused on executing what is in our control, but planning conservatively. We remain focused on positioning the company for longterm success.

Confident in our ability to build upon our advantage foundation and are excited for what we can accomplish for all of our key stakeholders as we had into 2020.

Things kind of look forward to speaking with you again next quarter.

Like you, ladies and gentlemen, like includes the Advansix third quarter 2019 earnings conference call.

<unk>. Thank you for joining us this morning.

Oh.

Oh.

[noise].

[noise] Oh.

[noise].

Q3 2019 Earnings Call

Demo

AdvanSix

Earnings

Q3 2019 Earnings Call

ASIX

Friday, November 1st, 2019 at 1:00 PM

Transcript

No Transcript Available

No transcript data is available for this event yet. Transcripts typically become available shortly after an earnings call ends.

Want AI-powered analysis? Try AllMind AI →